ConductScience.org, home

Paper41205697

Classification system proposed to guide the design, development, regulatory approval, and scaling of long acting, small- and macro-molecule parenteral products (CS-BLAP).

Perazzolo S and 2 others. J Pharm Sci, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Classification system proposed to guide the design, development, regulatory approval, and scaling of long acting, small- and macro-molecule parenteral products (CS-BLAP). Papers, record 41205697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41205697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Classification system proposed to guide the design, development, regulatory approval, and scaling of long acting, small- and macro-molecule parenteral products (CS-BLAP).
PubMed
Journal
J Pharm Sci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Perazzolo SSimone
2Shen DDDanny D
3Ho RJYRodney J Y

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Delayed-Action PreparationsMajor topic
Drug ApprovalMajor topic
Drug DevelopmentMajor topic
Biological ProductsMajor topic
Humans
Biopharmaceutics
Particle Size
Drug Delivery Systems
Drug Design
Pharmaceutical Preparations

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 AI148055NIAID NIH HHSUnited StatesU01AI148055PubMedNIH RePORTER
U01 HL152401NHLBI NIH HHSUnited StatesU01HL152401PubMedNIH RePORTER
R01 AI179309NIAID NIH HHSUnited StatesR01AI179309PubMedNIH RePORTER
UM1 AI120176NIAID NIH HHSUnited StatesUM1AI120176PubMedNIH RePORTER
R33 AI149665NIAID NIH HHSUnited StatesR33AI149665PubMedNIH RePORTER
R61 AI149665NIAID NIH HHSUnited StatesR61AI149665PubMedNIH RePORTER

Download CSV of grants

References77

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133166693Long-acting drugs and formulations for the treatment and prevention of HIV infection.Int J Antimicrob Agents2021https://conductscience.org/library/papers/33166693PubMed
211259830Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv Drug Deliv Rev2001https://conductscience.org/library/papers/11259830PubMed
337901442A biomimetic chip to assess subcutaneous bioavailability of monoclonal antibodies in humans.PNAS Nexus2023https://conductscience.org/library/papers/37901442PubMed
422411683Dermal clearance model for epidermal bioavailability calculations.J Pharm Sci2012https://conductscience.org/library/papers/22411683PubMed
537508373Solute Transport across the Lymphatic Vasculature in a Soft Skin Tissue.Biology (Basel)2023https://conductscience.org/library/papers/37508373PubMed
67988303Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.Diabetes Care1994https://conductscience.org/library/papers/7988303PubMed
722811424Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer.Physiol Rev2012https://conductscience.org/library/papers/22811424PubMed
840956864The Promises and Prospects of Long-Acting Therapeutics for Treatment and Prevention of Infectious Diseases.Annu Rev Pharmacol Toxicol2026https://conductscience.org/library/papers/40956864PubMed
910215751The absorption profile and availability of a physiological subcutaneously administered dose of recombinant human growth hormone (GH) in adults with GH deficiency.Br J Clin Pharmacol1999https://conductscience.org/library/papers/10215751PubMed
1011489331The physiology of the lymphatic system.Adv Drug Deliv Rev2001https://conductscience.org/library/papers/11489331PubMed
1135361288Editorial: Towards a better understanding of the physiology of the lymphatics.Inflamm Regen2022https://conductscience.org/library/papers/35361288PubMed
1225122564Pharmacokinetic modeling of the subcutaneous absorption of therapeutic proteins.Drug Metab Dispos2014https://conductscience.org/library/papers/25122564PubMed
1325100673Subcutaneous absorption of biotherapeutics: knowns and unknowns.Drug Metab Dispos2014https://conductscience.org/library/papers/25100673PubMed
1429388438Indocyanine green nanoparticles undergo selective lymphatic uptake, distribution and retention and enable detailed mapping of lymph vessels, nodes and abnormalities.J Drug Target2018https://conductscience.org/library/papers/29388438PubMed
1526886328Clarifications: Dermal Clearance Model for Epidermal Bioavailability Calculations.J Pharm Sci2016https://conductscience.org/library/papers/26886328PubMed
1630121315Three HIV Drugs, Atazanavir, Ritonavir, and Tenofovir, Coformulated in Drug-Combination Nanoparticles Exhibit Long-Acting and Lymphocyte-Targeting Properties in Nonhuman Primates.J Pharm Sci2018https://conductscience.org/library/papers/30121315PubMed
1731031702The Discovery and Development of Liraglutide and Semaglutide.Front Endocrinol (Lausanne)2019https://conductscience.org/library/papers/31031702PubMed
183321914Fluid and protein fluxes across small and large pores in the microvasculature. Application of two-pore equations.Acta Physiol Scand1987https://conductscience.org/library/papers/3321914PubMed
1926932471Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide.In Silico Pharmacol2016https://conductscience.org/library/papers/26932471PubMed
2029665381A Refined Developability Classification System.J Pharm Sci2018https://conductscience.org/library/papers/29665381PubMed

See all 77 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42084126A novel all-in-one injectable composed of tenofovir alafenamide-dolutegravir-lamivudine exhibits long-acting plasma and cell drug persistence for 8 weeks.AIDS2026https://conductscience.org/library/papers/42084126

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41205697

GET https://conductscience.org/api/papers/v1/41205697/references?page=2